The United States Drug Allergy Registry: A Prospective Longitudinal Cohort Study of Patients Tested for Drug Allergies

Authors

Kimberly Blumenthal
Allison Ramsey, Rochester Regional HealthFollow
S. Shahzad Mustafa, Rochester Regional HealthFollow
Holly Blue, Rochester Regional HealthFollow
Dawn Sheflin, Rochester Regional HealthFollow

Department

Allergy and Immunology

Document Type

Conference Proceeding

Publication Title

Journal of Allergy and Clinical Immunology

Conference Name

AAAAI Annual Meeting

Conference Date

2022-02-25

Abstract

Rationale: Drug allergy mislabeling negatively impacts clinical care and public health while preventing scientific advancements related to drug hypersensitivity. Given that single site US studies lack power and generalizability, we aimed to assemble the first multi-site US prospective longitudinal cohort of patients tested for drug allergies.

First Page

AB151

DOI

10.1016/j.jaci.2021.12.506

Volume

149

Issue

2

Publication Date

2-1-2022

Comments

See full list of authors at journal website.

Abstract 454

Recommended Citation

Blumenthal, K., Ramsey, A., Mustafa, S. S., Blue, H., & Sheflin, D. (2022). The United States Drug Allergy Registry: A Prospective Longitudinal Cohort Study of Patients Tested for Drug Allergies. Journal of Allergy and Clinical Immunology, 149 (2), AB151. https://doi.org/10.1016/j.jaci.2021.12.506